March 3, 2026RMD OpenOpen Access

Characteristics, treatments and outcomes of patients with dermatomyositis using real-world data

View Full Paper

Ask AI

Bookmark

Healthcare utilization is notably high in dermatomyositis patients, indicating a significant burden on the healthcare system.
Data reveals substantial glucocorticoid exposure among those diagnosed with dermatomyositis, emphasizing treatment challenges.
Observational analysis of administrative claims and EHR data examines treatment patterns and outcomes in dermatomyositis cohorts.
Findings suggest heterogeneity in treatment approaches, which may impact patient outcomes and overall disease management.

Implication

Observational analysis uncovers treatment patterns in dermatomyositis cohorts, highlighting significant healthcare utilization.

Abstract

Administrative claims and EHR data can be leveraged to assess treatment patterns and longitudinal outcomes/disease manifestations in incident dermatomyositis cohorts. This study highlights a high burden of glucocorticoid exposure, significant heterogeneity in treatment and high healthcare utilisation in this population.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

George et al. (2026) studied this question.

synapsesocial.com/papers/69a75b88c6e9836116a22f92 https://doi.org/10.1136/rmdopen-2025-006356

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis uncovers treatment patterns in dermatomyositis cohorts, highlighting significant healthcare utilization.

Characteristics, treatments and outcomes of patients with dermatomyositis using real-world data

Key Points

Implication

Abstract

Discussion

Cite This Study

Characteristics, treatments and outcomes of patients with dermatomyositis using real-world data

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading